May 27, 2016
Weill Cornell Medicine received a $100,000 Grand Challenges Explorations Grant from the Bill & Melinda Gates Foundation to develop maps that will help researchers better study antimicrobial resistance in 54 cities.
May 24, 2016
Researchers at Weill Cornell Medicine urge physicians to discuss patients' conditions and life expectancies after a recent study found that just 5 percent of advanced cancer patients fully understood their prognosis.
May 17, 2016
Weill Cornell Medicine has established the interdisciplinary Cardiovascular Research Institute, which will bring laboratory breakthroughs to clinical settings.
May 16, 2016
Two WCM physicians explained why they questioned a major study that served as the basis for national prostate cancer screening recommendations.
May 3, 2016
Peek inside NewYork-Presbyterian/Lower Manhattan’s new Birthing Center with NY1, which recently profiled the facility.
May 3, 2016
Learn more about the science of sneezing this allergy season. Weill Cornell Medicine’s Dr. William Reisacher discusses the reasons how and why we sneeze in a recent New York Times article.
April 28, 2016
Dr. Rahul Sharma was recently named the emergency physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center as well as the chief of the Division of Emergency Medicine at Weill Cornell Medicine.Dr. Sharma succeeds Dr. Neal Flomenbaum, who assumed a new role as chief of emergency medical services at NewYork-Presbyterian/Weill Cornell.In his new role, Dr. Sharma oversees all operations for the Lisa Perry Emergency Center at NewYork-... Read More
April 26, 2016
Scientists at Weill Cornell Medicine are exploring the relationship between cancer, the bacteria floating in and around our guts and antibiotics and anti-inflammatory drugs.
April 25, 2016
Weill Cornell Medicine is expanding New Yorkers’ access to its world-class physicians through a new partnership with Pager, an innovative mobile app that delivers on-demand healthcare services, including online chats and home and office visits.
April 25, 2016
A compound made from cranberries has shown promise in killing several cell lines and blood samples from an aggressive form of leukemia in humans as well as canine lymphoma, according to preliminary research from Weill Cornell Medicine.
